Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Flanders · SciRah

Researcher profile · Semantic Scholar

S. Flanders

Share profile

S. Flanders — researcher profile on SciRah

h-index: 22
Works: 89
Citations: 2,406

Most-cited papers

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.
M. Litwin, S. Flanders, D. Pasta, M. Stoddard +2 more
1999Urology252 citations
Semantic Scholar
Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
G. Grossfeld, James J. Chang, Jeanette M. Broering, Dave P. Miller +5 more
2000Journal of Urology229 citations
Semantic Scholar
Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE.
D. Lubeck, M. Litwin, J. Henning, M. Stoddard +2 more
1999Urology178 citations
Semantic Scholar
Fetal acidemia and electronic fetal heart rate patterns: Is there evidence of an association?
J. Parer, T. King, S. Flanders, Michael Fox +1 more
2006Journal of Maternal-Fetal & Neonatal Medicine173 citations
Semantic Scholar
Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
G. Grossfeld, James J. Chang, Jeanette M. Broering, Yu-Ping Li +3 more
2001Journal of Urology170 citations
Semantic Scholar
The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.
D. Penson, M. Stoddard, D. Pasta, D. Lubeck +2 more
2001Journal of Clinical Epidemiology167 citations
Semantic Scholar
Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
M. Litwin, D. Pasta, Jenny Yu, M. Stoddard +1 more
2000Journal of Urology163 citations
Semantic Scholar
Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
J. Moul, R. Connelly, D. Lubeck, J. Bauer +4 more
2001Journal of Urology132 citations
Semantic Scholar
Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.
G. Grossfeld, David M. Stier, S. Flanders, J. Henning +3 more
1998Journal of Urology123 citations
Semantic Scholar
Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor.
D. Lubeck, Howard H. Kim, G. Grossfeld, P. Ray +3 more
2001Journal of Urology121 citations
Semantic Scholar
Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
T. Koppie, G. Grossfeld, D. W. Miller, Jenny Yu +6 more
2000Journal of Urology80 citations
Semantic Scholar
Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer.
D. Stier, S. Greenfield, D. Lubeck, Kimberly A. Dukes +4 more
1999Urology77 citations
Semantic Scholar
Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science
N. Nussbaum, D. George, A. Abernethy, C. Dolan +3 more
2016Prostate Cancer and Prostatic Diseases71 citations Open access
Semantic Scholar
Quality of life before death for men with prostate cancer: results from the CaPSURE database.
M. Litwin, D. Lubeck, M. Stoddard, D. Pasta +2 more
2001Journal of Urology52 citations
Semantic Scholar
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.
D. Penson, Warren H. Schonfeld, S. Flanders, C. Henke +3 more
2001Urology37 citations
Semantic Scholar
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
N. Schultz, S. Flanders, S. Wilson, Bruce A. Brown +4 more
2018Advances in Therapy36 citations Open access
Semantic Scholar
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.
G. Grossfeld, James J. Chang, Jeanette M. Broering, Dave P. Miller +3 more
2000Urology36 citations
Semantic Scholar
Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System
M. Fuller, K. Shermock, P. Russo, M. Secic +3 more
2009Journal of Medical Economics34 citations
Semantic Scholar
Clinical and Economic Burden Associated With Stage III to IV Triple-Negative Breast Cancer: A SEER-Medicare Historical Cohort Study in Elderly Women in the United States
K. Schwartz, M. Simon, L. Bylsma, J. Ruterbusch +6 more
2018Cancer28 citations Open access
Semantic Scholar
Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents
J. Hafron, Helen M Wilfehrt, C. Ferro, Matthew Harmon +2 more
2022Advances in Therapy27 citations Open access
Semantic Scholar
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
D. Penson, M. Litwin, D. Lubeck, S. Flanders +2 more
1998Prostate Cancer and Prostatic Diseases24 citations
Semantic Scholar
Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
M. Massoudi, Mark Balk, Hong-Bo Yang, C. Bui +7 more
2017Journal of Medical Economics22 citations Open access
Semantic Scholar
Direct Health Care Costs for Children with Pervasive Developmental Disorders: 1996–2002
S. Flanders, L. Engelhart, G. Pandina, J. McCracken
2007Administration and Policy in Mental Health and Mental Health Services Research22 citations
Semantic Scholar
Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
C. Bui, K. O’Day, S. Flanders, N. Oestreicher +5 more
2016Journal of Managed Care & Specialty Pharmacy19 citations Open access
Semantic Scholar
A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer
R. McKay, J. Hafron, C. Ferro, Helen M Wilfehrt +4 more
2020Advances in Therapy16 citations Open access
Semantic Scholar
Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
J. Beebe-Dimmer, J. Ruterbusch, L. Bylsma, C. Gillezeau +6 more
2018Advances in Therapy14 citations Open access
Semantic Scholar
The economic burden of pervasive developmental disorders in a privately insured population.
S. Flanders, L. Engelhart, J. Whitworth, M. Hussein +2 more
2006Managed care interface14 citations
Semantic Scholar
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry
Xiao X. Wei, Lucia Kwak, A. Hamid, M. He +4 more
2022Prostate Cancer and Prostatic Diseases13 citations
Semantic Scholar
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey
B. C. Medeiros, B. Pandya, A. Hadfield, J. Pike +6 more
2019Current Medical Research and Opinion13 citations Open access
Semantic Scholar
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations
A. Armstrong, C. Bui, Kathryn Fitch, T. Sawhney +5 more
2017Current Medical Research and Opinion8 citations
Semantic Scholar
Does race predict development of metastases in men on ADT after biochemical recurrence following radical prostatectomy?
Adriana C. Vidal, L. Howard, A. D. De Hoedt, C. Kane +7 more
2018Cancer7 citations Open access
Semantic Scholar
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research
D. Penson, D. Lin, L. Karsh, D. Quinn +7 more
2016Future Oncology7 citations Open access
Semantic Scholar
Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999–2003
S. Flanders, R. Findling, E. Youngstrom, G. Pandina +3 more
2007Journal of child and adolescent psychopharmacology5 citations
Semantic Scholar
THE IMPACT OF TRAINING ON THE PERIOPERATIVE AND INTERMEDIATE FUNCTIONAL OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE
D. Lin, L. Karsh, D. Quinn, D. Shevrin +9 more
20154 citations
Semantic Scholar
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
N. Schultz, N. Shore, S. Chowdhury, L. Klotz +7 more
2018BMC Urology3 citations Open access
Semantic Scholar
Sipuleucel-T (sip-T) and oral androgen axis inhibitors in black men being treated for metastatic castration-resistance prostate cancer (mCRPC): Observations from the Medicare Fee for Service (FFS) population.
H. Borno, K. Moses, P. Monk, Kate Fitch +3 more
20202 citations
Semantic Scholar
Impact of flu vaccine on survival after immunotherapy for metastatic castration resistant prostate cancer (mCRPC): Analysis of Medicare claims data.
R. Pachynski, R. McKay, J. Hafron, Kate Fitch +2 more
20202 citations
Semantic Scholar
Interpreting survival outcomes for African-American (AA) patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with sipuleucel-T (SIP-T) with number needed to treat to benefit (NNTB).
K. Moses, S. Flanders, Matthew Harmon, N. Chang +3 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Health care resource utilization and costs in metastatic castration-resistant prostate cancer patients treated with enzalutamide or abiraterone acetate.
V. Kassabian, S. Flanders, Samuel D. Wilson, Bruce A. Brown +4 more
20182 citations
Semantic Scholar
Treatment patterns and associated adverse events among patients with metastatic triple-negative breast cancer.
V. Kaklamani, N. Schultz, D. Irwin, N. Fulcher +6 more
20172 citations
Semantic Scholar
Real-world study of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or abiraterone acetate plus prednisone (AA+P): Patient characteristics and treatment persistence.
K. Moses, D. Penson, N. Schultz, Fei Shi +4 more
20172 citations
Semantic Scholar
Hospital admissions (HA) among chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients newly treated with enzalutamide (ENZA) or abiraterone (ABI).
R. Quek, A. Gilligan, Shia T. Kent, C. Gregory +5 more
20172 citations
Semantic Scholar
Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks.
S. Flanders, Bruce A. Brown, M. Massoudi, N. Schultz +1 more
2017Journal of Managed Care & Specialty Pharmacy2 citations Open access
Semantic Scholar
Approaches to Missing Data Inference Results from CaPSURE
D. Lubeck, D. Pasta, S. Flanders, J. Henning
1999PharmacoEconomics (Auckland)2 citations
Semantic Scholar
Effects of age on outcomes in men receiving treatment for metastatic castration-resistant prostate cancer (mCRPC): Analysis of Medicare fee for service (FFS) claims data.
T. Dorff, R. McKay, C. Olsson, Kate Fitch +2 more
20201 citations
Semantic Scholar
Real-world experience with sipuleucel-T (Sip-T) in Asian men with castrate-resistant prostate cancer (CRPC).
Jing-Song Zhang, Ming Liu, Jia-Hua Pan, Xiao X. Wei +3 more
20201 citations
Semantic Scholar
Overall survival (OS) among Medicare beneficiaries receiving sipuleucel-T (sip-T) versus oral treatment for metastatic castration-resistant prostate cancer (mCRPC).
R. McKay, S. Flanders, C. Ferro, Kate Fitch +2 more
20201 citations
Semantic Scholar
MP22-07 INDIRECT COMPARISON OF SURVIVAL AND COST PER NUMBER NEEDED TO TREAT TO BENEFIT ANALYSIS OF ABIRATERONE, ENZALUTAMIDE, AND SIPULEUCEL-T IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
S. Flanders, B. Lowentritt, J. Hafron, Bruce A. Brown +1 more
2019Journal of Urology1 citations
Semantic Scholar
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
S. Flanders, Janet S. Kim, Samuel D. Wilson, Jeffrey Braziunas +10 more
2018Future Oncology1 citations Open access
Semantic Scholar
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
N. Schultz, N. Shore, S. Chowdhury, L. Klotz +7 more
2018BMC Urology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Bruce A. Brown×11
Invite
Bruce A. Brown — researcher profile on SciRah
D. Lubeck×10
Invite
D. Lubeck — researcher profile on SciRah
N. Schultz×10
Invite
N. Schultz — researcher profile on SciRah
J. Henning×8
Invite
J. Henning — researcher profile on SciRah

×8

Invite

D. Penson — researcher profile on SciRah

Invite

A. Barlev — researcher profile on SciRah

Invite

M. Litwin — researcher profile on SciRah

G. Grossfeld×7

Invite

G. Grossfeld — researcher profile on SciRah

Invite

R. McKay — researcher profile on SciRah

Invite

D. Pasta — researcher profile on SciRah

Invite

M. Stoddard — researcher profile on SciRah

P. R. Carroll×5

Invite

P. R. Carroll — researcher profile on SciRah